News for the Multiple Sclerosis Community

Dirucotide (MBP8298) trial recommended to continue

There's no real new data here, but it is good to know that dirucotide has passed the data safety monitoring board review for its MAESTRO-01 trial. This drug is being tested on people with SPMS, which is unique.